Sort   by:  
 Page size 
UnknownPreliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.
Not available
S-EPMC8622332 | biostudies-literature
UnknownSex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Not available
S-EPMC6687727 | biostudies-literature
UnknownLeadership Effectiveness in Healthcare Settings: A Systematic Review and Meta-Analysis of Cross-Sectional and Before-After Studies.
Not available
S-EPMC9518077 | biostudies-literature
UnknownGenetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Not available
S-EPMC4220280 | biostudies-literature
UnknownDihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
Not available
S-EPMC5709672 | biostudies-literature
UnknownPrevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study).
Not available
S-EPMC9907511 | biostudies-literature
Sort   by:  
 Page size